,32,33 We tested the antitumor potential of MITO-66-conditioned CD19-CAR T cells following adoptive cell transfer in an NALM6-based mouse model of pre-B cell acute lymphoblastic leukemia. Here, CD19 is linked to B-cell acute lymphoblastic leukemia.